Once a fierce contender for BMW, the Acura TLX ends production. Explore the history and performance of the sedan that almost ...

Telix Pharmaceuticals' strong sales, diverse pipeline, and theranostics promise support a Buy rating, despite SEC concerns.

In Cars.com’s most popular news story of the past week, we break down the 2026 Toyota Corolla. See the full list of stories ...

Honda's Anna Engine Plant celebrates 40 years of production, with over 32 million engines built. Discover how this plant will ...

We're saying goodbye to a lovely sports sedan -- the 2025 Acura TLX Type S . So what does the final model drive like?

Let’s talk about a vehicle that’s sparking conversations and turning heads in the automotive world—the 2024 Acura TLX Type S.

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today advises that it will release its financial results for ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ ...

Get the latest Telix Pharmaceuticals Limited (TLX) stock news and headlines to help you in your trading and investing decisions.

Here are a couple of ASX 200 shares that analysts are tipping to rise strongly from current levels. Here's what you need to ...

Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are ...

Detailed price information for Telix Pharmaceutical Ltd (TLPPF) from The Globe and Mail including charting and trades.